A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study. [electronic resource]
Producer: 20110801Description: 39 p. digitalISSN:- 1756-9966
- Adult
- Aged
- Alopecia -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Neoplasms -- drug therapy
- Breast Neoplasms -- drug therapy
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Epirubicin -- administration & dosage
- Female
- Humans
- Kaplan-Meier Estimate
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Polyethylene Glycols -- administration & dosage
- Prospective Studies
- Soft Tissue Neoplasms -- drug therapy
- Vinblastine -- administration & dosage
- Vinorelbine
- Viscera -- pathology
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.